US EditionPublished • loading... • Updated
Isomorphic signs another pharma deal, partnering with J&J for AI-made drugs
Summary by endpoints.news
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Isomorphic signs another pharma deal, partnering with J&J for AI-made drugs
The Google DeepMind spinout Isomorphic Labs has landed its third pharma deal. The AI-focused biotech has signed a multi-target research deal with Johnson & Johnson, the two companies announced Tuesday. Isomorphic, founded in 2021 and ...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
